Michael D. Serby
Ain Shams University(EG)Eli Lilly (United States)(US)AbbVie (United States)(US)
Publications by Year
Research Areas
Regulation of Appetite and Obesity, Biochemical Analysis and Sensing Techniques, Melanoma and MAPK Pathways, Hepatitis C virus research, HIV/AIDS drug development and treatment
Most-Cited Works
- → Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity(2006)159 cited
- → Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors(2007)117 cited
- → Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites(2016)88 cited
- → Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors(2004)81 cited
- → Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors(2008)76 cited
- → Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide c-Jun NH2-Terminal Kinase Inhibitors(2006)75 cited
- → Discovery and Pharmacological Evaluation of Growth Hormone Secretagogue Receptor Antagonists(2006)50 cited
- → 2,4-Diaminopyrimidine Derivatives as Potent Growth Hormone Secretagogue Receptor Antagonists(2006)45 cited
- → Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors(2007)28 cited
- → Synthesis and structure–activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists(2004)20 cited